secwatch.observer — SEC 8-K summary
======================================

Issuer:     Orchestra BioMed Holdings, Inc. (OBIO)
CIK:        0001814114
Form:       8-K
Filed at:   2024-08-12T23:59:59+00:00
Accession:  0001104659-24-088431
Event type: other_material
Sentiment:  neutral
Materiality: 0.55
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Orchestra BioMed enters $100M ATM sales agreement with TD Cowen, terminates Jefferies facility
--------------------------------------------------------------------------------

- New sales agreement with TD Securities (USA) LLC for up to $100M of common stock in at-the-market offerings.
- Prior $100M ATM agreement with Jefferies LLC terminated; $15.5M had been sold under it, $84.5M remained unused.
- Termination intended to eliminate restrictions on Jefferies publishing research reports on the company.
- Offering is under existing shelf registration statement (filed May 2024); no obligation to sell any shares.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1814114/000110465924088431/0001104659-24-088431-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1814114/000110465924088431/tm2421432d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-24-088431

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer